Available Structures

10 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the PTPN3 PDZ domain bound to the HPV18 E6 oncoprotein C-terminal peptide Heteromer
P26045;
148-158
NA;
Assess
CFTR Associated Ligand (CAL) PDZ domain bound to HPV18 E6 oncoprotein C-terminal peptide (RLQRRRETQâ€Ĥ Heteromer
Q9HD26;
149-158
GOL;
Assess
Crystal structure of Scribble PDZ1 with human papillomavirus strain 16 E6 peptide Heteromer
Q14160;
149-158
CL;
Assess
X-ray crystal structure of MAGI-1 PDZ1 bound to the C-terminal peptide of HPV18 E6 Heteromer
Q6RHR9;
152-158
SO4;
Assess
CAL PDZ mutant C319A with a peptide Heteromer
Q9HD26;
153-158
Assess
CAL PDZ domain with peptide and inhibitor Heteromer
Q9HD26;
153-158
PQR;
Assess
X-ray crystal structure of Sap97 PDZ2 bound to the C-terminal peptide of HPV18 E6. Heteromer
Q62696;
153-158
Assess
X-ray crystal structure of Sap97 PDZ3 bound to the C-terminal peptide of HPV18 E6 Heteromer
Q62696;
153-158
Assess
14-3-3 zeta chimera with 18E6 and fusicoccinhomo-2-mer152-158
GOL;FSC;
Assess
14-3-3 zeta bound to the phosphorylated 18E6 C-terminushomo-2-mer152-158
GOL;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6sjv.1.Bhomo-2-mer0.925-143
ZN;98.00
Assess
7uaj.1.Amonomer0.718-145
ZN;57.14
Assess